Stocks in Focus

"Explosive Growth Expected in Q2"…APR Up 6% [Featured Stock]

[Edaily Reporter Kwon Oh-seok] #APR's stock price is surging in early trading. It appears that buying interest is surging on the back of positive forecasts from the securities industry.

According to MP Doctor on the 9th, as of 9:25 a.m., APR is trading at 388,500 won, up 6.15% from the previous trading day.
Earlier today, Hana Securities released a report setting a target price of 510,000 won for APR, forecasting that "explosive earnings growth will continue into the second quarter." APR previously reported consolidated revenue of 593.4 billion won and operating profit of 152.3 billion won for the first quarter of this year. These figures represent increases of 123% and 173.7% year-over-year, respectively, exceeding market expectations.
Park Jong-dae, an analyst at Hana Securities, noted, “In the U.S., following the termination of the Alta Beauty contract, the company is now actively expanding into other major retailers.” He added, “Supply shortages have persisted for several quarters, particularly for the Zero Pore Pad. If bottlenecks ease in the second half due to the expansion of ODM (Original Design Manufacturing) and packaging facilities, revenue could reach a new milestone.”
Park added, “Earnings estimates continue to be revised upward due to the comprehensive expansion of overseas operations through diversification across regions, categories, and channels,” noting, “It is still difficult to gauge just how much sales will increase.”

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02